Cargando…
iPSC technology‐based regenerative therapy for diabetes
The directed differentiation of human pluripotent stem cells, such as embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs), into pancreatic endocrine lineages has been vigorously examined by reproducing the in vivo developmental processes of the pancreas. Recent advances in this...
Autores principales: | Kondo, Yasushi, Toyoda, Taro, Inagaki, Nobuya, Osafune, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835458/ https://www.ncbi.nlm.nih.gov/pubmed/28609558 http://dx.doi.org/10.1111/jdi.12702 |
Ejemplares similares
-
iPSC technology-based regenerative medicine for kidney diseases
por: Osafune, Kenji
Publicado: (2021) -
Elucidation of HHEX in pancreatic endoderm differentiation using a human iPSC differentiation model
por: Ito, Ryo, et al.
Publicado: (2023) -
Regenerative therapy for spinal cord injury using iPSC technology
por: Nagoshi, Narihito, et al.
Publicado: (2020) -
iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
por: Turhan, Ali G., et al.
Publicado: (2021) -
Purification of human iPSC-derived cells at large scale using microRNA switch and magnetic-activated cell sorting
por: Tsujisaka, Yuta, et al.
Publicado: (2022)